Brief: Xeris Biopharma Subsidiaries File Recorlev Patent Infringement Lawsuit
26/02/2026 23:01
Feb 26 (Reuters) - Xeris Biopharma Holdings Inc XERS.O: XERIS BIOPHARMA SUBSIDIARIES FILE RECORLEV® PATENT INFRINGEMENT LAWSUIT XERIS BIOPHARMA HOLDINGS INC: INTENDS TO ENFORCE AND DEFEND ITS INTELLECTUAL PROPERTY RIGHTS RELATING TO RECORLEV XERIS BIOPHARMA HOLDINGS: FILED PATENT INFRINGEMENT LAWSUIT RELATED TO RECORLEV AGAINST TORRENT PHARMACEUTICALS & SOMERSET THERAPEUTICS Source text: ID:nBw3PrKyCa Further company coverage: XERS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest